QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.056705v1 307/3/1142    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Qiao, N. Articles by Pace-Asciak, C. R. Search for Related Content PubMed PubMed Citation Articles by Qiao, N. Articles by Pace-Asciak, C. R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL

CARDIOVASCULAR

The Thromboxane Receptor Antagonist PBT-3, a Hepoxilin Stable Analog, Selectively Antagonizes the TP Isoform in Transfected COS-7 Cells

Programme in Integrative Biology, Research Institute, the Hospital for Sick Children, Toronto, Canada (N.Q., D.R., P.D., C.R.P.-A.); Departments of Cell and Molecular Pharmacology and Experimental Therapeutics and Medicine, Medical University of South Carolina, Charleston, South Carolina (P.H.); and Department of Pharmacology, Faculty of Medicine, University of Toronto, Toronto, Canada (C.R.P.-A.)

The hepoxilin analog PBT-3 [10(S)-hydroxy-11,12-cyclopropyleicosa-5Z,8Z,14Z-trienoic acid methyl ester] was previously shown to inhibit the aggregation of human platelets and to antagonize the binding of the thromboxane receptor agonist I-BOP [[1S-[1,2 (Z),3(1E,3S*),4]]-7-[3-[3-hydroxy-4-(4-iodophenoxy)-1-butenyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid] in human platelets (Pace-Asciak et al., 2002). We show herein that PBT-3 inhibits, to different degrees, binding of the TP receptor antagonist [³H]SQ 29,548 [[1S-[1,2 (Z),3,4]]-7-[3-[[2-[(phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2. 1]hept-2-yl]-5-heptenoic acid], to the TP receptor isoforms in TP- and TP-transfected COS-7 cells. These isoforms possess a different tail length, the being shorter than the isoform. In contrast, SQ 29,548 shows no selection for the two TP isoforms. The IC₅₀ value for PBT-3 = 2.0 ± 0.3 x 10^–7 M was observed for TP, whereas this was one-sixth less active on the TP isoform (IC₅₀ = 1.2 ± 0.2 x 10^–6 M), suggesting selectivity for the TP isoform. To investigate whether the tail contributes to the difference in competition binding by PBT-3, we investigated the tailless TP isoform expressed in transfected COS-7 cells. Its IC₅₀ was similar to that of the TP isoform. In additional studies, we investigated the effect of PBT-3 on the collagen and I-BOP evoked intracellular calcium release and on the collagen and I-BOP evoked phosphorylation of pleckstrin. PBT-3 blocked both pathways further demonstrating its TP receptor antagonist activity. These results demonstrate that the action of PBT-3 in inhibiting platelet aggregation is mediated via inhibition of the TP isoform of the thromboxane receptor and that the tail may play an important role in recognition of this TP receptor antagonist.

Address correspondence to: Prof. Cecil R. Pace-Asciak, Research Institute, The Hospital for Sick Children, 555 University Ave., Toronto, ON, Canada M5G 1X8. E-mail: pace{at}sickkids.ca

This article has been cited by other articles:

				J. Hanson, S. Rolin, D. Reynaud, N. Qiao, L. P. Kelley, H. M. Reid, F. Valentin, J. Tippins, B. T. Kinsella, B. Masereel, et al. In Vitro and in Vivo Pharmacological Characterization of BM-613 [N-n-Pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a Novel Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 293 - 301. [Abstract] [Full Text] [PDF]

				C. Lefevre, B. Bouadjar, A. Karaduman, F. Jobard, S. Saker, M. Ozguc, M. Lathrop, J.-F. Prud'homme, and J. Fischer Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis Hum. Mol. Genet., October 1, 2004; 13(20): 2473 - 2482. [Abstract] [Full Text] [PDF]